# Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults

> **NCT00623753** · PHASE1 · TERMINATED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 3 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** EnvDNA, PolyEnv1, EnvPro

## Key facts

- **NCT ID:** NCT00623753
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623753, "Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00623753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*